Skip to main content

CITADEL ADVISORS LLC

Position in GPCR — Structure Therapeutics Inc.

CIK 1423053 MIAMI, FL

Position in GPCR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
-$53,728,626 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
13 quarters on record

Common Shares in GPCR Over Time

Shares Held

Position Value (USD)

Derivatives in GPCR

reported options exposure · as of Mar 31, 2026
CallValue
$2,896,820
CallShares
60,100
PutValue
$2,617,260
PutShares
54,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,784,241,435 across 374 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in GPCR

Export CSV
32 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,896,820 60,100
2026-03-31 $2,617,260 54,300
2025-12-31 $53,728,626 772,518
2025-12-31 $3,811,340 54,800
2025-12-31 $5,515,315 79,300
2025-09-30 $12,426,400 443,800
2025-09-30 $2,335,200 83,400
2025-09-30 $3,082,800 110,100
2025-06-30 $1,684,088 81,200
2025-06-30 $1,847,934 89,100
2025-06-30 $27,552,653 1,328,479
2025-03-31 $773,757 44,700
2025-03-31 $2,030,463 117,300
2025-03-31 $17,177,405 992,340
2024-12-31 $4,019,184 148,200
2024-12-31 $40,119,672 1,479,339
2024-12-31 $759,360 28,000
2024-09-30 $1,992,606 45,400
2024-09-30 $2,962,575 67,500
2024-09-30 $63,706,246 1,451,498
2024-06-30 $3,667,818 93,400
2024-06-30 $55,307,278 1,408,385
2024-06-30 $2,670,360 68,000
2024-03-31 $3,973,122 92,700
2024-03-31 $54,683,444 1,275,862
2024-03-31 $2,082,996 48,600
2023-12-31 $46,995,668 1,152,985
2023-12-31 $1,557,032 38,200
2023-12-31 $998,620 24,500
2023-09-30 $54,483,448 1,080,592
2023-06-30 $14,535,490 349,663
2023-03-31 $8,713,967 366,287